From: [C upi] at [clari.net] (UPI) Newsgroups: clari.news.issues.smoking,clari.tw.health.misc,clari.tw.top Subject: CWRU: Nicotine Inhibits Alzheimer's Organization: Copyright 1996 by United Press International Date: Tue, 5 Nov 1996 14:30:49 PST CLEVELAND, Nov. 5 (UPI) -- Researchers at Case Western Reserve University have found, in test tube studies, that nicotine inhibits the formation of amyloid plaque. The CWRU researchers say that toxic substance found in the brains of Alzheimer's patients is the suspected cause of the dementia of memory loss. The research work was conducted by Michael Zagorski, an assistant professor in CWRU's Department of Chemistry. His team reported the findings in the Oct. 22 issue of ``Biochemistry,'' a journal of the American Chemical Society. Amyloid plaques are abundant in Alzheimer's victims' brains, and the major component of the plaques is the beta-peptide. The beta-peptide is normally found in everyone's blood plasma and other fluids. However, under certain environmental changes, the beta-peptides undergo a transformation from a soluble form to one that is toxic to nerve cells. Both forms are elementary structures found in strings of amino acids that make up proteins and peptides. Working under Zagorski's supervision, Arthur Salomon (who at the time was an undergraduate student and now a graduate student at Stanford University) performed the experiments that showed nicotine inhibits production of the toxic beta-sheet structures and the accompanying formation of amyloid plaques. Graduate students also participating in the research included Shu- chuan Jao, Keith Marcinowski, and Haiyan Shao. Robert Friedland from the Department of Neurology in CWRU's School of Medicine also contributed to the study. ``This model may later facilitate the development of nicotine-like compounds that could prevent or slow down amyloid formation in AD patients,'' said Zagorski. He stressed that nicotine in tobacco is hazardous to human health, and that cigarette smoking should not be considered as a method to delay or prevent the onset of Alzheimer's disease. -- C O P Y R I G H T * R E M I N D E R This article is Copyright 1996 by United Press International. All articles in the clari.* news hierarchy are Copyrighted and licensed to ClariNet Communications Corp. for distribution. Except for articles in the biz.clarinet.sample newsgroup, only paid subscribers may access these articles. Any unauthorized access, reproduction or transmission is strictly prohibited. We offer a reward to the person who first provides us with information that helps stop those who distribute or receive our news feeds without authorization. Please send reports to [r--wa--d] at [clari.net.] [Use [i--o] at [clari.net] for sales or other inquiries.] Details on use of ClariNet material and other info can be found in the user documentation section of our web page: . You can also read ClariNet news from your Web browser.